|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | |
| C07D 401/04 | |||
| C07D 239/28 | |||
| C07D 239/42 |
| (11) | Number of the document | 2912030 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13779841.9 |
| Date of filing the European patent application | 2013-10-21 | |
| (97) | Date of publication of the European application | 2015-09-02 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/071996 |
| Date | 2013-10-21 |
| (87) | Number | WO 2014/064058 |
| Date | 2014-05-01 |
| (30) | Number | Date | Country code |
| 201261717237 P | 2012-10-23 | US | |
| 201361842101 P | 2013-07-02 | US |
| (72) |
FLUBACHER, Dietmar, CH
BIERI, Nicole, CH
ACEMOGLU, Murat, CH
MICHEL, Pascal, CH
MOSE, Rasmus, CH
STETTLER, Hans, CH
TESTA, Maria Caterina, CH
BROZIO, Jörg, CH
SCHAEFER, Frank, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | IMPROVED PROCESS FOR MANUFACTURING 5-(2,6-DI-4-MORPHOLINYL-4-PYRIMIDINYL)-4-TRIFLUOROMETHYLPYRIDIN-2-AMINE |
| IMPROVED PROCESS FOR MANUFACTURING 5-(2,6-DI-4-MORPHOLINYL-4-PYRIMIDINYL)-4-TRIFLUOROMETHYLPYRIDIN-2-AMINE |